Zimmer Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Zimmer Biomet Holdings
ZBH Stock  USD 97.16  0.71  0.74%   
Zimmer Biomet's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Zimmer Biomet's valuation are provided below:
Gross Profit
5.9 B
Profit Margin
0.0857
Market Capitalization
19.1 B
Enterprise Value Revenue
3.1637
Revenue
8.2 B
We have found one hundred twenty available fundamental gauges for Zimmer Biomet Holdings, which can be analyzed and compared to other ratios and to its peers. Traders should compare all of Zimmer Biomet Holdings prevalent fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year.

Zimmer Biomet Total Revenue

5.19 Billion

Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 553.6 M, Interest Expense of 151.7 M or Selling General Administrative of 2.2 B, as well as many indicators such as Price To Sales Ratio of 2.05, Dividend Yield of 0.0151 or PTB Ratio of 1.33. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
Build AI portfolio with Zimmer Stock
Check out the analysis of Zimmer Biomet Correlation against competitors.

Zimmer Biomet Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding164.7 M198.7 M194.9 M
Slightly volatile
Total Assets14.5 B23.1 B18.6 B
Slightly volatile
Other Current Liabilities2.1 B2 B1.2 B
Slightly volatile
Total Current Liabilities1.6 B2.6 B2.1 B
Slightly volatile
Total Stockholder Equity7.9 B12.7 B9.5 B
Slightly volatile
Property Plant And Equipment Net1.4 B2.2 B1.7 B
Slightly volatile
Accounts Payable229.3 M223.8 M266.5 M
Slightly volatile
Non Current Assets Total10.9 B18 B14.3 B
Slightly volatile
Non Currrent Assets Other628 M1.1 B844.8 M
Slightly volatile
Net Receivables1 B1.7 B1.2 B
Slightly volatile
Liabilities And Stockholders Equity14.5 B23.1 B18.6 B
Slightly volatile
Non Current Liabilities Total5 B7.8 B7 B
Slightly volatile
Inventory1.4 B2.3 B1.8 B
Slightly volatile
Other Current Assets394.3 M537.2 M442.2 M
Slightly volatile
Total Liabilities6.6 B10.4 B9 B
Slightly volatile
Property Plant And Equipment Gross8.1 B7.7 B3.5 B
Slightly volatile
Total Current Assets3.5 B5.1 B4.3 B
Slightly volatile
Other Liabilities1.2 B1.3 B1.6 B
Pretty Stable
Other Assets1.2 B1.1 B718 M
Slightly volatile
Property Plant Equipment1.5 B2.2 B1.7 B
Slightly volatile
Short and Long Term Debt Total5 B7.5 B6.7 B
Pretty Stable
Net Debt3.9 B6.9 B5.3 B
Slightly volatile
Retained Earnings7 B12.8 B8.7 B
Slightly volatile
Cash593.1 M591.9 M664.1 M
Slightly volatile
Long Term Debt4.3 B6.9 B5.5 B
Slightly volatile
Cash And Short Term Investments723.5 M591.9 M826.5 M
Slightly volatile
Common Stock Total Equity2.9 M3.6 M2.9 M
Slightly volatile
Short Term Debt557.7 M587.1 M1.3 B
Very volatile
Common Stock3 M3.7 M2.9 M
Slightly volatile
Good Will6.5 B9.9 B7.3 B
Slightly volatile
Intangible Assets4 B4.7 B4.9 B
Slightly volatile
Retained Earnings Total Equity9.1 B11 B8.8 B
Slightly volatile
Capital Surpluse7.9 B11.5 B7.6 B
Slightly volatile
Non Current Liabilities Other1 B855.7 M943.3 M
Slightly volatile
Long Term Debt Total6.4 B6.9 B5.6 B
Slightly volatile
Long Term Investments73.1 M69.6 M39.9 M
Slightly volatile
Short and Long Term Debt1.4 B776.7 M1.3 B
Very volatile
Cash And Equivalents440.7 M591.9 M573.8 M
Slightly volatile
Net Invested Capital13.3 B16.8 B18.6 B
Slightly volatile
Net Working Capital2 B2.6 B1.8 B
Slightly volatile
Capital Stock3.4 M3.7 M3.2 M
Slightly volatile

Zimmer Biomet Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization553.6 M1.1 B747.2 M
Slightly volatile
Selling General Administrative2.2 B3.2 B2.6 B
Slightly volatile
Total Revenue5.2 B8.2 B6.2 B
Slightly volatile
Gross Profit3.7 B5.1 B4.4 B
Slightly volatile
Other Operating Expenses4.3 B6.9 B5.3 B
Slightly volatile
Operating Income861 M1.4 B825.9 M
Slightly volatile
EBIT852.9 M1.1 B787 M
Pretty Stable
Research Development273.9 M458.5 M325.6 M
Slightly volatile
EBITDA1.4 B2.2 B1.5 B
Slightly volatile
Cost Of Revenue3.3 B3.2 B1.9 B
Slightly volatile
Total Operating Expenses2.9 B3.7 B3.5 B
Slightly volatile
Selling And Marketing Expenses180.3 M304.8 M244.5 M
Slightly volatile
Non Recurring410.1 M336.7 M355.3 M
Pretty Stable
Interest Income179.2 M292.8 M189 M
Very volatile
Reconciled Depreciation807.1 M896.7 M1 B
Slightly volatile

Zimmer Biomet Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow949.2 M1.5 B1.1 B
Slightly volatile
Begin Period Cash Flow595.7 M525.5 M705.9 M
Slightly volatile
Depreciation558.9 M1.1 B755.4 M
Slightly volatile
Capital Expenditures199.1 M224.5 M188.3 M
Slightly volatile
Total Cash From Operating Activities1.1 B1.7 B1.3 B
Slightly volatile
End Period Cash Flow597.5 M591.9 M701.1 M
Slightly volatile
Stock Based Compensation77 M116.2 M73.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.052.16293.3339
Slightly volatile
Dividend Yield0.01510.01070.0138
Slightly volatile
PTB Ratio1.331.40132.7491
Slightly volatile
Days Sales Outstanding55.975.576371.7427
Slightly volatile
Book Value Per Share67.3864.170749.7451
Slightly volatile
Free Cash Flow Yield0.0420.08270.0575
Pretty Stable
Operating Cash Flow Per Share9.08.57076.7284
Slightly volatile
Stock Based Compensation To Revenue0.01310.01510.0116
Pretty Stable
Capex To Depreciation0.190.20520.2867
Slightly volatile
PB Ratio1.331.40132.7491
Slightly volatile
EV To Sales4.853.00454.1825
Pretty Stable
Free Cash Flow Per Share7.817.43695.759
Slightly volatile
ROIC0.05210.05480.0696
Slightly volatile
Inventory Turnover1.281.38191.0875
Slightly volatile
Days Of Inventory On Hand263264349
Pretty Stable
Payables Turnover10.6410.137.057
Slightly volatile
Sales General And Administrative To Revenue0.340.380.4137
Slightly volatile
Research And Ddevelopement To Revenue0.04180.05570.0511
Slightly volatile
Capex To Revenue0.0450.02730.0303
Slightly volatile
Cash Per Share2.742.98944.3594
Slightly volatile
POCF Ratio20.3110.491516.7004
Very volatile
Interest Coverage4.424.65239.1265
Slightly volatile
Capex To Operating Cash Flow0.20.13230.1456
Slightly volatile
PFCF Ratio11.4912.091118.9097
Very volatile
Days Payables Outstanding69.1237.2859.6832
Slightly volatile
EV To Operating Cash Flow22.6814.573620.6779
Very volatile
EV To Free Cash Flow28.2616.795524.66
Pretty Stable
Intangibles To Total Assets0.460.63510.581
Slightly volatile
Net Debt To EBITDA1.933.1243.4989
Pretty Stable
Current Ratio2.791.98162.4943
Slightly volatile
Receivables Turnover5.834.82965.1116
Pretty Stable
Graham Number36.5471.710658.7063
Slightly volatile
Shareholders Equity Per Share67.3864.170749.7346
Slightly volatile
Debt To Equity0.660.59180.8404
Slightly volatile
Capex Per Share0.71.13380.9391
Slightly volatile
Revenue Per Share43.6541.573232.3207
Slightly volatile
Interest Debt Per Share41.4339.45432.0435
Slightly volatile
Debt To Assets0.180.32560.3013
Very volatile
Enterprise Value Over EBITDA13.2611.153317.5038
Very volatile
Short Term Coverage Ratios2.752.8905116
Pretty Stable
Operating Cycle319340421
Pretty Stable
Price Book Value Ratio1.331.40132.7491
Slightly volatile
Days Of Payables Outstanding69.1237.2859.6832
Slightly volatile
Price To Operating Cash Flows Ratio20.3110.491516.7004
Very volatile
Price To Free Cash Flows Ratio11.4912.091118.9097
Very volatile
Operating Profit Margin0.220.16550.1503
Slightly volatile
Company Equity Multiplier2.261.81741.9176
Pretty Stable
Long Term Debt To Capitalization0.220.3530.3519
Pretty Stable
Total Debt To Capitalization0.230.37180.3762
Pretty Stable
Return On Capital Employed0.06310.06640.0934
Slightly volatile
Debt Equity Ratio0.660.59180.8404
Slightly volatile
Ebit Per Revenue0.220.16550.1503
Slightly volatile
Quick Ratio1.751.09671.5513
Slightly volatile
Dividend Paid And Capex Coverage Ratio5.194.09114.1203
Slightly volatile
Net Income Per E B T0.740.84881.0685
Very volatile
Cash Ratio0.220.22910.4233
Slightly volatile
Cash Conversion Cycle271340365
Slightly volatile
Operating Cash Flow Sales Ratio0.250.20620.2136
Pretty Stable
Days Of Inventory Outstanding263264349
Pretty Stable
Days Of Sales Outstanding55.975.576371.7427
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.660.86770.8457
Slightly volatile
Cash Flow Coverage Ratios0.210.22570.318
Slightly volatile
Price To Book Ratio1.331.40132.7491
Slightly volatile
Fixed Asset Turnover4.873.72963.9793
Slightly volatile
Capital Expenditure Coverage Ratio5.667.5597.881
Slightly volatile
Price Cash Flow Ratio20.3110.491516.7004
Very volatile
Enterprise Value Multiple13.2611.153317.5038
Very volatile
Debt Ratio0.180.32560.3013
Very volatile
Cash Flow To Debt Ratio0.210.22570.318
Slightly volatile
Price Sales Ratio2.052.16293.3339
Slightly volatile
Asset Turnover0.660.35650.4464
Slightly volatile
Gross Profit Margin0.80.61620.7156
Pretty Stable
Price Fair Value1.331.40132.7491
Slightly volatile

Zimmer Biomet Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap12.9 B14.6 B15.9 B
Slightly volatile
Enterprise Value12.8 B14.4 B15.7 B
Slightly volatile

Zimmer Fundamental Market Drivers

Forward Price Earnings11.3895
Cash And Short Term Investments591.9 M

Zimmer Upcoming Events

8th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Zimmer Biomet Financial Statements

Investors use fundamental indicators, such as Zimmer Biomet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-35 M-36.7 M
Total Revenue8.2 B5.2 B
Cost Of Revenue3.2 B3.3 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.38  0.34 
Research And Ddevelopement To Revenue 0.06  0.04 
Capex To Revenue 0.03  0.05 
Revenue Per Share 41.57  43.65 
Ebit Per Revenue 0.17  0.22 

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
How To Invest In Zimmer
Details
Is Zimmer Stock a good investment?
Details
What is Zimmer Biomet's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Zimmer Biomet Correlation against competitors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is there potential for Health Care Equipment & Supplies market expansion? Will Zimmer introduce new products? Factors like these will boost the valuation of Zimmer Biomet. Anticipated expansion of Zimmer directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.41)
Dividend Share
0.96
Earnings Share
3.55
Revenue Per Share
41.573
Quarterly Revenue Growth
0.109
Zimmer Biomet Holdings's market price often diverges from its book value, the accounting figure shown on Zimmer's balance sheet. Smart investors calculate Zimmer Biomet's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Zimmer Biomet's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY